A newly identified lncRNA H1FX-AS1 targets DACT1 to inhibit cervical cancer via sponging miR-324-3p

Table 1 The relationship between H1FX-AS1 expression and the clinicopathological characteristics of CC patients was analyzed by Chi square test

Clinicopathological characteristics	Total	High expression	Low expression	X²	P value
Age
≤ 35	28	12	16	1.299	0.254
> 35	22	13	9	1.299	0.254
Differentiation
High	17	8	9	0.111	0.946
Moderate	14	7	7
Poor	19	10	9
Tumor size (cm)
< 4	28	18	10	5.195	0.023
≥ 4	22	7	15	5.195	0.023
TMN stages
I	15	12	3	14.274	0.003
II	11	7	4
III	13	5	8
IV	11	1	10
Lymph node metastasis
Positive	21	6	15	6.650	0.010
Negative	29	19	10	6.650	0.010

The 50 CC patients were divided into H1FX-AS1 low expression group (n = 25) and H1FX-AS1 high expression group (n = 25) with the cut-off value of H1FX-AS1 median expression in CC tissues

ISSN: 1475-2867